Oralis Cavicare0.022%

Oralis Cavicare is a mineral supplement and topical dental agent used mainly for the prevention of dental caries (tooth decay).

Established / Guideline-Supported Uses

• Dietary fluoride supplementation in children (from about 6 months of age) living in areas where the drinking water is fluoride-deficient, as tablets, chewable tablets, lozenges, or drops (ADA/AAP-supported).
• Topical caries prevention in children and adults as fluoride toothpaste, gel, varnish, or oral rinse to reduce the incidence of dental caries.
• Prescription-strength fluoride rinses/gels for patients at high risk of caries (e.g. reduced salivary flow from radiotherapy or Sjögren syndrome, orthodontic appliances, xerostomia).

Adjunct / Less Common Uses

• Adjunctive management of dentin hypersensitivity.
• Historically used as adjunct therapy for osteoporosis to increase bone density; this use is largely obsolete and not an approved indication in most markets due to an unfavorable risk-benefit profile.

Oralis Cavicare does not replace regular brushing, flossing, and routine dental check-ups.

Sodium Fluoride is available in several strengths and dosage forms depending on the intended use:

• Chewable/oral tablets or lozenges: 0.25 mg, 0.5 mg, and 1 mg fluoride ion equivalent.
• Oral drops: approximately 0.5 mg fluoride ion per mL.
• Oral rinse (over-the-counter): approximately 0.05% Sodium Fluoride (0.02% fluoride ion).
• Prescription-strength oral rinse/gel: approximately 0.2% Sodium Fluoride (0.09% fluoride ion).
• Dental gel for professional or home application: 1.1% Sodium Fluoride.

Strength and formulation available may vary by brand and market.

Oralis Cavicare is an inorganic fluoride salt used as a source of fluoride ion in dentistry and, historically, in bone metabolism. It is one of the most widely used agents for the prevention of dental caries worldwide and is added to community water supplies, toothpaste, and mouth rinses in many countries as a public health measure.

Oralis Cavicare is available as oral supplement tablets/drops for systemic fluoride intake in children in fluoride-deficient areas, and as topical products (rinses, gels, varnishes, toothpaste) for direct application to the teeth.

Mineral (trace element) supplement; Dental caries prophylactic agent

Mechanism of Action

Sodium Fluoride provides fluoride ion, which is incorporated into the hydroxyapatite crystal of developing and erupted tooth enamel to form fluorapatite, a structure that is more resistant to acid dissolution by cariogenic oral bacteria.

• Pre-eruptive (systemic) effect: incorporation of fluoride into developing enamel during tooth formation, producing a more acid-resistant crystal lattice.
• Post-eruptive (topical) effect: promotes remineralization of early carious lesions, inhibits demineralization, and reduces the acid-producing and enzymatic activity of cariogenic bacteria such as Streptococcus mutans.

Pharmacokinetics

Ingested Sodium Fluoride is rapidly and almost completely absorbed from the gastrointestinal tract. Absorbed fluoride distributes into calcified tissues (bone, developing teeth) and is eliminated primarily by the kidneys, with the rate of renal excretion influenced by urinary pH.

Oral Oralis Cavicare tablets or lozenges should be chewed or allowed to dissolve slowly in the mouth (for maximum topical benefit) before swallowing, ideally at bedtime after toothbrushing, on an empty stomach or apart from dairy products. Drops may be placed directly on the tongue or in a small amount of water or juice. Rinses and gels are for topical dental use only, applied as directed, and must be expectorated rather than swallowed.

• Calcium, magnesium, and aluminum-containing products (milk, dairy products, antacids, calcium/magnesium supplements): form insoluble complexes with fluoride ion, significantly reducing absorption of oral Oralis Cavicare. Separate administration by at least 1–2 hours.
• Other systemic fluoride sources (fluoridated water, other fluoride supplements or dental products): concurrent use increases the risk of dental fluorosis and should be avoided; total fluoride intake from all sources should be assessed before prescribing Oralis Cavicare.

• Dental fluorosis: white/brown mottling or pitting of permanent teeth, occurring with chronic excessive fluoride intake during tooth development (before about 8 years of age); this is the most clinically important adverse effect of Oralis Cavicare.
• Gastrointestinal upset: nausea, stomach pain, or vomiting, particularly if taken on an empty stomach or in excess.
• Hypersensitivity reactions: rare — skin rash, itching, or, very rarely, more significant allergic-type reactions.
• Local irritation of the mouth or staining with topical rinse/gel overuse.

Data on the use of Oralis Cavicare in pregnancy are limited. Systemic fluoride supplementation during pregnancy has not been shown to provide additional benefit to the offspring and is generally not recommended for the purpose of preventing caries in the child. Oralis Cavicare should be used in pregnancy only if clearly needed and if the potential benefit justifies the potential risk to the fetus; a physician should be consulted before use.

Fluoride is excreted in breast milk in small amounts. Oralis Cavicare should be used during breastfeeding only under medical advice, weighing the mother's need for supplementation against the infant's total fluoride exposure.

• Keep Oralis Cavicare products out of reach of children — accidental ingestion of larger amounts (e.g. flavored toothpaste, rinse) can cause acute gastrointestinal toxicity.
• Confirm the fluoride content of the patient's primary drinking water before prescribing systemic Oralis Cavicare, and periodically reassess if the water source changes.
• Use the lowest effective dose in children under 6–8 years old to minimize the risk of dental fluorosis of the permanent teeth, which are still developing.
• Oralis Cavicare is not a substitute for good oral hygiene, a balanced diet, and regular professional dental care.
• Rinses and gels are for dental/topical use only and must not be swallowed.

Acute overdose of Oralis Cavicare can cause nausea, vomiting, abdominal pain, excess salivation, and diarrhea; larger overdoses can cause hypocalcemia, muscle weakness, cardiac arrhythmia, seizures, and, rarely, be fatal. Chronic excessive intake causes dental (and, with very high long-term intake, skeletal) fluorosis.

Suspected overdose of Oralis Cavicare is a medical emergency — seek immediate medical attention or contact a poison control center/emergency services right away. Do not attempt specific home treatment; supportive care (e.g., calcium-containing fluids while awaiting emergency care) may be advised by a medical professional, but management should be directed by trained personnel.

Store at room temperature (below 30°C), away from light and moisture. Keep out of reach of children.

• Children: systemic Oralis Cavicare supplementation is only appropriate from about 6 months of age in fluoride-deficient areas, dosed per the age-based schedule (see Dosage and Administration); avoid excess intake before age 8 due to fluorosis risk in developing permanent teeth.
• Elderly: no specific dose adjustment established; topical use is generally preferred, particularly in patients with dry mouth or root caries risk.
• Renal impairment: fluoride is renally excreted; use with caution in significant renal impairment or dialysis patients, as accumulation may increase fluorosis/toxicity risk — dose adjustment or avoidance of routine systemic supplementation may be warranted, and a physician should individualize therapy.
• Hepatic impairment: no specific dose adjustment is established.

Systemic Oralis Cavicare supplementation is generally continued from initiation until the primary drinking water source is no longer fluoride-deficient, or until eruption of the permanent teeth is essentially complete (commonly up to around 16 years of age), whichever comes first. Duration should be reassessed periodically by a physician or dentist, including re-testing water fluoride content if the household water supply changes. Topical products (toothpaste, rinse) are typically used long-term/indefinitely as part of routine oral hygiene, as directed.

Trace element/mineral supplement; Dental caries prophylactic (anticariogenic) agent

Sodium Fluoride supplies fluoride ion, which converts tooth enamel hydroxyapatite into more acid-resistant fluorapatite, inhibits demineralization and bacterial acid production, and enhances remineralization of early carious lesions.

Oralis Cavicare dietary supplementation is used in children from about 6 months of age who live in areas with fluoride-deficient drinking water, dosed according to age and water fluoride concentration (see Dosage and Administration). Safety and efficacy of routine supplementation in infants younger than 6 months have not been established, and supplementation is not recommended in this age group. Because of the risk of dental fluorosis to the developing permanent teeth, doses above the recommended schedule should be avoided in children under 8 years of age, and use of fluoride toothpaste in young children should be limited to a pea-sized (or smaller) amount under adult supervision, with instructions not to swallow.